Forte Biosciences, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$3.94 | -$3.94 | -$3.94 |
| Q2 2024 | 1 | -$6.33 | -$6.33 | -$6.33 |
| Q3 2024 | 1 | -$2.99 | -$2.99 | -$2.99 |
| Q1 2025 | 1 | -$5.75 | -$5.75 | -$5.75 |
| Q2 2025 | 1 | -$1.50 | -$1.50 | -$1.50 |
| Q3 2025 | 1 | -$1.75 | -$1.75 | -$1.75 |
| Q4 2025 | 1 | -$1.75 | -$1.75 | -$1.75 |
Forte Biosciences, Inc. Earnings Date And Information
Forte Biosciences, Inc. last posted its earnings results on Thursday, November 14th, 2024. The company reported $-4.54 earnings per share for the quarter, topping analysts' consensus estimates of $-6.75 by $2.21. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Forte Biosciences, Inc. has generated $-25 earnings per share over the last year ($-24.92 diluted earnings per share) and currently has a price-to-earnings ratio of -0.85. Forte Biosciences, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 17th, 2025 based on prior year's report dates.
Forte Biosciences, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/14/2024 | Q3 2024 | -$6.75 | -$4.54 | 2.21 | $0 | $0 |
| 08/14/2024 | Q2 2024 | -$4.00 | -$6.78 | -2.78 | $0 | $0 |
| 05/13/2024 | Q1 2024 | -$0.16 | -$4.03 | -3.87 | $0 | |
| 04/29/2024 | Q4 2023 | -$4.04 | $6,000 | |||
| 11/13/2023 | Q3 2023 | -$6.57 | $0 | |||
| 08/14/2023 | Q2 2023 | -$10.57 | $0 | |||
| 05/15/2023 | Q1 2023 | -$8.04 | $0 | |||
| 03/31/2023 | Q4 2022 | -$0.16 | -$5.81 | -5.65 | $0 | |
| 11/14/2022 | Q3 2022 | -$0.15 | -$4.49 | -4.34 | $0 | |
| 08/15/2022 | Q2 2022 | -$5.14 | $0 | |||
| 05/16/2022 | Q1 2022 | -$4.35 | $0 | |||
| 03/31/2022 | Q4 2021 | -$0.32 | -$5.66 | -5.34 | $0 | |
| 11/08/2021 | Q3 2021 | -$7.25 | -$13.61 | -6.36 | $0 | |
| 08/16/2021 | Q2 2021 | -$10.00 | -$10.68 | -0.68 | $0 | |
| 05/10/2021 | Q1 2021 | -$9.75 | -$9.06 | 0.69 | $0 | |
| 03/15/2021 | Q4 2020 | -$0.57 | -$8.92 | -8.35 | $0 | |
| 11/09/2020 | Q3 2020 | -$8.00 | -$11.37 | -3.37 | $0 | |
| 08/10/2020 | Q2 2020 | -$0.19 | -$238.06 | -237.87 | $0 | |
| 04/23/2020 | Q1 2020 | -$6.60 | -$161.28 | -154.68 | $0 | |
| 02/27/2020 | Q4 2019 | -$8.55 | -$166.06 | -157.51 | $9,000 |
Forte Biosciences, Inc. Earnings: Frequently Asked Questions
-
When is Forte Biosciences, Inc.'s earnings date?
Forte Biosciences, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 17th, 2025 based off last year's report dates.
-
Did Forte Biosciences, Inc. beat their earnings estimates last quarter?
In the previous quarter, Forte Biosciences, Inc. (:FBRX) reported $-4.54 earnings per share (EPS) to beat the analysts' consensus estimate of $-6.75 by $2.21.
-
How can I listen to Forte Biosciences, Inc.'s earnings conference call?
The conference call for Forte Biosciences, Inc.'s latest earnings report can be listened to online.
-
How can I read Forte Biosciences, Inc.'s conference call transcript?
The conference call transcript for Forte Biosciences, Inc.'s latest earnings report can be read online.
-
How much profit does Forte Biosciences, Inc. generate each year?
Forte Biosciences, Inc. (:FBRX) has a recorded net income of $0. Forte Biosciences, Inc. has generated $-24.92 earnings per share over the last four quarters.
-
What is Forte Biosciences, Inc.'s price-to-earnings ratio?
Forte Biosciences, Inc. (:FBRX) has a price-to-earnings ratio of -0.85 and price/earnings-to-growth ratio is -0.03.
